author
William J. McClellan
A pharmaceutical researcher whose work helped explore promising compounds in cancer biology, William J. McClellan contributed to studies of Aurora kinase inhibitors, BCL-2 antagonists, and BET bromodomain inhibitors.
1 Audiobook
Earth's Gone to the Dogs!
by William J. McClellan
About the author
William J. McClellan is a medicinal chemistry researcher associated with Abbott Laboratories’ Global Pharmaceutical Research and Development group in Illinois, later represented in publications under AbbVie’s name. His research focused on discovering and refining small-molecule compounds with potential applications in cancer treatment.
His published work includes a 2006 study of B-cell lymphoma 2 family protein antagonists, a 2011 paper on selective Aurora kinase inhibitors, and a 2017 study of BET bromodomain inhibitors. These collaborative projects brought together researchers in medicinal chemistry, cancer biology, and drug discovery.
McClellan’s publications place him among the behind-the-scenes scientists whose contributions support the development of new therapeutic approaches, particularly in oncology and targeted drug research.